Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	complement component C3b receptor activity	CR1 CR1L	7.18e-06	2	54	2	GO:0004877
GeneOntologyMolecularFunction	complement component C4b receptor activity	CR1 CR1L	7.18e-06	2	54	2	GO:0001861
GeneOntologyMolecularFunction	MHC class Ib protein binding	KIR2DS4 KIR3DL2 LILRB1	1.02e-05	16	54	3	GO:0023029
GeneOntologyMolecularFunction	MHC class Ib receptor activity	KIR2DS4 KIR3DL2 LILRB1	1.76e-05	19	54	3	GO:0032394
GeneOntologyMolecularFunction	complement component C4b binding	CR1 CR1L	2.15e-05	3	54	2	GO:0001855
GeneOntologyMolecularFunction	Toll-like receptor 2 binding	TLR1 TLR6	4.29e-05	4	54	2	GO:0035663
GeneOntologyMolecularFunction	immune receptor activity	KIR2DS4 CR1 CR1L KIR3DL2 LILRB1	8.27e-05	165	54	5	GO:0140375
GeneOntologyMolecularFunction	opsonin receptor activity	CR1 CR1L	1.99e-04	8	54	2	GO:0001847
GeneOntologyMolecularFunction	transmembrane signaling receptor activity	CD3E EFNA4 PTPRZ1 TLR1 TLR6 KIR2DS4 CR1 CR1L PTGER2 KIR3DL2 LILRB1 OR10D4P	2.13e-04	1353	54	12	GO:0004888
GeneOntologyMolecularFunction	lipopeptide binding	TLR1 TLR6	3.19e-04	10	54	2	GO:0071723
GeneOntologyMolecularFunction	complement component C3b binding	CR1 CR1L	4.66e-04	12	54	2	GO:0001851
GeneOntologyMolecularFunction	MHC protein binding	KIR2DS4 KIR3DL2 LILRB1	5.19e-04	58	54	3	GO:0042287
GeneOntologyMolecularFunction	complement receptor activity	CR1 CR1L	6.40e-04	14	54	2	GO:0004875
GeneOntologyMolecularFunction	NAD+ nucleotidase, cyclic ADP-ribose generating	TLR1 TLR6	8.41e-04	16	54	2	GO:0061809
GeneOntologyMolecularFunction	T cell receptor binding	DOCK2 CD3E	1.32e-03	20	54	2	GO:0042608
GeneOntologyMolecularFunction	virus receptor activity	DPP4 CR1 ITGB5	1.58e-03	85	54	3	GO:0001618
GeneOntologyMolecularFunction	exogenous protein binding	DPP4 CR1 ITGB5	1.63e-03	86	54	3	GO:0140272
GeneOntologyMolecularFunction	opsonin binding	CR1 CR1L	2.07e-03	25	54	2	GO:0001846
GeneOntologyMolecularFunction	Toll-like receptor binding	TLR1 TLR6	2.78e-03	29	54	2	GO:0035325
GeneOntologyMolecularFunction	complement binding	CR1 CR1L	3.38e-03	32	54	2	GO:0001848
GeneOntologyMolecularFunction	immunoglobulin binding	UMOD LILRB1	4.26e-03	36	54	2	GO:0019865
GeneOntologyMolecularFunction	hydrolase activity, hydrolyzing N-glycosyl compounds	TLR1 TLR6	5.50e-03	41	54	2	GO:0016799
GeneOntologyBiologicalProcess	detection of bacterial lipopeptide	TLR1 TLR6	2.09e-05	3	55	2	GO:0070340
GeneOntologyBiologicalProcess	immune response-regulating signaling pathway	A1BG CD3E TLR1 TLR6 KIR2DS3 KIR2DS4 CR1 KIR3DL2 LILRB1	3.28e-05	615	55	9	GO:0002764
GeneOntologyBiologicalProcess	detection of bacterial lipoprotein	TLR1 TLR6	4.17e-05	4	55	2	GO:0042494
GeneOntologyBiologicalProcess	regulation of immune response	A1BG DPP4 CD3E TLR1 TLR6 KIR2DS3 KIR2DS4 CR1 CR1L KIR3DL2 LILRB1	1.15e-04	1085	55	11	GO:0050776
GeneOntologyBiologicalProcess	negative regulation of serotonin secretion	MAOB LILRB1	1.45e-04	7	55	2	GO:0014063
GeneOntologyBiologicalProcess	negative regulation of complement activation, classical pathway	CR1 CR1L	1.93e-04	8	55	2	GO:0045959
GeneOntologyBiologicalProcess	response to insecticide	INHBB NR4A2	2.48e-04	9	55	2	GO:0017085
GeneOntologyBiologicalProcess	cellular response to bacterial lipoprotein	TLR1 TLR6	3.10e-04	10	55	2	GO:0071220
GeneOntologyBiologicalProcess	cellular response to bacterial lipopeptide	TLR1 TLR6	3.10e-04	10	55	2	GO:0071221
GeneOntologyBiologicalProcess	response to bacterial lipopeptide	TLR1 TLR6	3.10e-04	10	55	2	GO:0070339
GeneOntologyBiologicalProcess	regulation of complement activation, classical pathway	CR1 CR1L	3.10e-04	10	55	2	GO:0030450
GeneOntologyBiologicalProcess	adhesion of symbiont to host cell	DPP4 INHBB	3.10e-04	10	55	2	GO:0044650
GeneOntologyBiologicalProcess	T cell costimulation	DPP4 CD3E TNFSF14	3.41e-04	51	55	3	GO:0031295
GeneOntologyBiologicalProcess	response to bacterial lipoprotein	TLR1 TLR6	3.78e-04	11	55	2	GO:0032493
GeneOntologyBiologicalProcess	lymphocyte costimulation	DPP4 CD3E TNFSF14	3.82e-04	53	55	3	GO:0031294
GeneOntologyBiologicalProcess	regulation of serotonin secretion	MAOB LILRB1	4.53e-04	12	55	2	GO:0014062
GeneOntologyBiologicalProcess	negative regulation of humoral immune response mediated by circulating immunoglobulin	CR1 CR1L	4.53e-04	12	55	2	GO:0002924
GeneOntologyBiologicalProcess	regulation of cell-cell adhesion mediated by integrin	DPP4 CD3E	4.53e-04	12	55	2	GO:0033632
GeneOntologyBiologicalProcess	myoblast fusion	DOCK2 TNFSF14 DYRK1B	4.99e-04	58	55	3	GO:0007520
GeneOntologyBiologicalProcess	regulation of complement-dependent cytotoxicity	CR1 CR1L	5.34e-04	13	55	2	GO:1903659
GeneOntologyBiologicalProcess	regulation of toll-like receptor 2 signaling pathway	TLR1 TLR6	5.34e-04	13	55	2	GO:0034135
GeneOntologyBiologicalProcess	cellular defense response	UMOD KIR2DS3 KIR3DL2	5.51e-04	60	55	3	GO:0006968
GeneOntologyBiologicalProcess	negative thymic T cell selection	DOCK2 CD3E	6.22e-04	14	55	2	GO:0045060
GeneOntologyBiologicalProcess	negative regulation of complement activation	CR1 CR1L	6.22e-04	14	55	2	GO:0045916
GeneOntologyBiologicalProcess	negative T cell selection	DOCK2 CD3E	7.17e-04	15	55	2	GO:0043383
GeneOntologyBiologicalProcess	negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	CR1 CR1L LILRB1	7.29e-04	66	55	3	GO:0002823
GeneOntologyBiologicalProcess	detection of molecule of bacterial origin	TLR1 TLR6	8.18e-04	16	55	2	GO:0032490
GeneOntologyBiologicalProcess	negative regulation of B cell mediated immunity	CR1 CR1L	8.18e-04	16	55	2	GO:0002713
GeneOntologyBiologicalProcess	negative regulation of immunoglobulin mediated immune response	CR1 CR1L	8.18e-04	16	55	2	GO:0002890
GeneOntologyBiologicalProcess	complement-dependent cytotoxicity	CR1 CR1L	8.18e-04	16	55	2	GO:0097278
GeneOntologyBiologicalProcess	positive regulation of leukocyte activation	DPP4 CD3E TNFSF14 TLR6 CR1 LILRB1	8.91e-04	423	55	6	GO:0002696
GeneOntologyBiologicalProcess	negative regulation of adaptive immune response	CR1 CR1L LILRB1	9.02e-04	71	55	3	GO:0002820
GeneOntologyBiologicalProcess	activation of NF-kappaB-inducing kinase activity	TLR1 TLR6	9.25e-04	17	55	2	GO:0007250
GeneOntologyBiologicalProcess	T cell mediated immunity	DPP4 CR1 CR1L LILRB1	9.37e-04	163	55	4	GO:0002456
GeneOntologyBiologicalProcess	T cell proliferation	DOCK2 CD3E TNFSF14 CR1 LILRB1	1.01e-03	288	55	5	GO:0042098
GeneOntologyBiologicalProcess	positive thymic T cell selection	DOCK2 CD3E	1.04e-03	18	55	2	GO:0045059
GeneOntologyBiologicalProcess	positive regulation of T cell activation	DPP4 CD3E TNFSF14 CR1 LILRB1	1.04e-03	290	55	5	GO:0050870
GeneOntologyBiologicalProcess	serotonin secretion	MAOB LILRB1	1.16e-03	19	55	2	GO:0001820
GeneOntologyBiologicalProcess	negative regulation of humoral immune response	CR1 CR1L	1.16e-03	19	55	2	GO:0002921
GeneOntologyBiologicalProcess	cell-cell adhesion mediated by integrin	DPP4 CD3E	1.16e-03	19	55	2	GO:0033631
GeneOntologyBiologicalProcess	toll-like receptor 2 signaling pathway	TLR1 TLR6	1.16e-03	19	55	2	GO:0034134
GeneOntologyBiologicalProcess	positive regulation of cell activation	DPP4 CD3E TNFSF14 TLR6 CR1 LILRB1	1.21e-03	449	55	6	GO:0050867
GeneOntologyBiologicalProcess	detection of bacterium	TLR1 TLR6	1.29e-03	20	55	2	GO:0016045
GeneOntologyBiologicalProcess	adhesion of symbiont to host	DPP4 INHBB	1.29e-03	20	55	2	GO:0044406
GeneOntologyCellularComponent	membrane raft	DPP4 MYOF TLR1 TLR6 CR1 CR1L	3.67e-04	362	55	6	GO:0045121
GeneOntologyCellularComponent	membrane microdomain	DPP4 MYOF TLR1 TLR6 CR1 CR1L	3.78e-04	364	55	6	GO:0098857
MousePheno	abnormal blood urea nitrogen level	UBR1 TMPRSS15 GLIS2 DYRK1B UMOD TNS2 CR1 CR1L	2.07e-05	389	43	8	MP:0005265
Domain	ZP_1	OIT3 TECTB UMOD	8.13e-06	14	54	3	PS00682
Domain	ZP_2	OIT3 TECTB UMOD	8.13e-06	14	54	3	PS51034
Domain	ZP	OIT3 TECTB UMOD	1.01e-05	15	54	3	SM00241
Domain	ZP_dom	OIT3 TECTB UMOD	1.51e-05	17	54	3	IPR001507
Domain	Zona_pellucida	OIT3 TECTB UMOD	1.51e-05	17	54	3	PF00100
Domain	ig	A1BG SIGLEC6 KIR2DS3 KIR2DS4 KIR3DL2 LILRB1	1.76e-05	190	54	6	PF00047
Domain	Immunoglobulin	A1BG SIGLEC6 KIR2DS3 KIR2DS4 KIR3DL2 LILRB1	1.76e-05	190	54	6	IPR013151
Domain	CK1gamma_C	CSNK1G2 CSNK1G1	2.46e-05	3	54	2	PF12605
Domain	Casein_kinase-1_gamma_C	CSNK1G2 CSNK1G1	2.46e-05	3	54	2	IPR022247
Domain	EGF	RSPO3 OIT3 LAMA1 UMOD HABP2 ITGB5	5.80e-05	235	54	6	SM00181
Domain	Toll-like_receptor	TLR1 TLR6	8.16e-05	5	54	2	IPR017241
Domain	-	A1BG FLNC CD3E PTPRZ1 SIGLEC6 KIR2DS3 KIR2DS4 KIR3DL2 LILRB1	1.08e-04	663	54	9	2.60.40.10
Domain	Ig-like_fold	A1BG FLNC CD3E PTPRZ1 SIGLEC6 KIR2DS3 KIR2DS4 KIR3DL2 LILRB1	1.73e-04	706	54	9	IPR013783
Domain	ZP_dom_CS	TECTB UMOD	3.64e-04	10	54	2	IPR017977
Domain	Sushi	APOH CR1 CR1L	4.57e-04	52	54	3	PF00084
Domain	IG_LIKE	A1BG CD3E SIGLEC6 KIR2DS3 KIR2DS4 KIR3DL2 LILRB1	5.06e-04	491	54	7	PS50835
Domain	CCP	APOH CR1 CR1L	5.11e-04	54	54	3	SM00032
Domain	SUSHI	APOH CR1 CR1L	5.68e-04	56	54	3	PS50923
Domain	Ig-like_dom	A1BG CD3E SIGLEC6 KIR2DS3 KIR2DS4 KIR3DL2 LILRB1	5.84e-04	503	54	7	IPR007110
Domain	Sushi_SCR_CCP_dom	APOH CR1 CR1L	5.99e-04	57	54	3	IPR000436
Domain	EGF_1	OIT3 LAMA1 UMOD HABP2 ITGB5	8.36e-04	255	54	5	PS00022
Domain	EGF_2	OIT3 LAMA1 UMOD HABP2 ITGB5	9.93e-04	265	54	5	PS01186
Domain	IG	A1BG SIGLEC6 KIR2DS3 KIR2DS4 KIR3DL2 LILRB1	1.31e-03	421	54	6	SM00409
Domain	Ig_sub	A1BG SIGLEC6 KIR2DS3 KIR2DS4 KIR3DL2 LILRB1	1.31e-03	421	54	6	IPR003599
Domain	TIR	TLR1 TLR6	1.66e-03	21	54	2	SM00255
Domain	TIR	TLR1 TLR6	1.83e-03	22	54	2	PF01582
Domain	-	TLR1 TLR6	2.00e-03	23	54	2	3.40.50.10140
Domain	TIR	TLR1 TLR6	2.17e-03	24	54	2	PS50104
Domain	TIR_dom	TLR1 TLR6	2.36e-03	25	54	2	IPR000157
Domain	LRRCT	TLR1 TLR6	3.85e-03	32	54	2	PF01463
Domain	IGc2	A1BG CD3E SIGLEC6 LILRB1	4.72e-03	235	54	4	SM00408
Domain	Ig_sub2	A1BG CD3E SIGLEC6 LILRB1	4.72e-03	235	54	4	IPR003598
Domain	EGF_CA	OIT3 UMOD HABP2	5.29e-03	122	54	3	SM00179
Domain	EGF-like_Ca-bd_dom	OIT3 UMOD HABP2	5.54e-03	124	54	3	IPR001881
Domain	EGF-like_dom	OIT3 LAMA1 UMOD HABP2	5.79e-03	249	54	4	IPR000742
Domain	EGF	UMOD HABP2 ITGB5	5.79e-03	126	54	3	PF00008
Domain	EGF-like_CS	LAMA1 UMOD HABP2 ITGB5	6.82e-03	261	54	4	IPR013032
Pubmed	Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains.	KIR2DS3 KIR2DS4 KIR3DL2	3.12e-07	9	55	3	7749980
Pubmed	Alternatively spliced forms of human killer inhibitory receptors.	KIR2DS3 KIR2DS4 KIR3DL2	3.12e-07	9	55	3	8662091
Pubmed	HLA-F and MHC class I open conformers are ligands for NK cell Ig-like receptors.	KIR2DS4 KIR3DL2 LILRB1	4.46e-07	10	55	3	24018270
Pubmed	New genetic associations detected in a host response study to hepatitis B vaccine.	CD3E TNFSF14 SIGLEC6 UMOD SLC35G2 TLR6 APOH CR1 PTGER2 ITGB5	5.89e-07	824	55	10	20237496
Pubmed	[Relationship between CMV reactivation and KIR haplotype/HLA-Cw genotype in patients after unrelated-donor hematopoietic stem cell transplantation.].	KIR2DS3 KIR2DS4 KIR3DL2	8.15e-07	12	55	3	20137308
Pubmed	Frequencies of killer immunoglobulin-like receptor genotypes influence susceptibility to spontaneous abortion.	KIR2DS3 KIR2DS4 KIR3DL2	1.35e-06	14	55	3	19875891
Pubmed	Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population.	KIR2DS3 KIR2DS4 KIR3DL2	1.35e-06	14	55	3	15896204
Pubmed	[Genotype and haplotype analysis of killer cell immunoglobulin-like receptors in ankylosing spondylitis].	KIR2DS3 KIR2DS4 KIR3DL2	1.35e-06	14	55	3	19489269
Pubmed	Killer cell immunoglobulin-like receptor gene diversity in a Caucasian population of southern Brazil.	KIR2DS3 KIR2DS4 KIR3DL2	1.68e-06	15	55	3	20082646
Pubmed	Disparate distribution of activating and inhibitory killer cell immunoglobulin-like receptor genes in patients with systemic lupus erythematosus.	KIR2DS3 KIR2DS4 KIR3DL2	1.68e-06	15	55	3	19926642
Pubmed	[Killer cell immunoglobin-like receptor and its ligand gene polymorphisms in Hunan Han patients with type 1 diabetes].	KIR2DS3 KIR2DS4 KIR3DL2	1.68e-06	15	55	3	20356536
Pubmed	Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.	KIR2DS3 KIR2DS4 KIR3DL2	1.68e-06	15	55	3	20643584
Pubmed	KIR genes polymorphism in Argentinean Caucasoid and Amerindian populations.	KIR2DS3 KIR2DS4 KIR3DL2	1.68e-06	15	55	3	17498266
Pubmed	Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.	KIR2DS3 KIR2DS4 KIR3DL2	1.68e-06	15	55	3	19326408
Pubmed	Killer cell immunoglobulin-like receptor gene-cluster 3DS1-2DL5-2DS1-2DS5 predisposes susceptibility to Vogt-Koyanagi-Harada syndrome in Japanese individuals.	KIR2DS3 KIR2DS4 KIR3DL2	2.07e-06	16	55	3	19897003
Pubmed	Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Java, Kalimantan, Timor and Irian Jaya.	KIR2DS3 KIR2DS4 KIR3DL2	2.07e-06	16	55	3	19000141
Pubmed	Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Sumatra, Sulawesi and Moluccas Islands.	KIR2DS3 KIR2DS4 KIR3DL2	2.07e-06	16	55	3	20670355
Pubmed	Activating killer cell immunoglobulin-like receptor genes' association with recurrent miscarriage.	KIR2DS3 KIR2DS4 KIR3DL2	2.07e-06	16	55	3	19527230
Pubmed	Polymorphisms of KIR gene and HLA-C alleles: possible association with susceptibility to HLA-B27-positive patients with ankylosing spondylitis.	KIR2DS3 KIR2DS4 KIR3DL2	2.07e-06	16	55	3	20652381
Pubmed	Asian population frequencies and haplotype distribution of killer cell immunoglobulin-like receptor (KIR) genes among Chinese, Malay, and Indian in Singapore.	KIR2DS3 KIR2DS4 KIR3DL2	2.07e-06	16	55	3	18668235
Pubmed	Influence of activating and inhibitory killer immunoglobulin-like receptors on predisposition to recurrent miscarriages.	KIR2DS3 KIR2DS4 KIR3DL2	2.07e-06	16	55	3	19279038
Pubmed	No association of KIR genes with Behcet's disease.	KIR2DS3 KIR2DS4 KIR3DL2	2.07e-06	16	55	3	17868255
Pubmed	A study of the killer cell immunoglobulin-like receptor gene KIR2DS1 in a Caucasoid Brazilian population with psoriasis vulgaris.	KIR2DS3 KIR2DS4 KIR3DL2	2.07e-06	16	55	3	18643961
Pubmed	Distribution of killer cell immunoglobulin-like receptor (KIR) genotypes in patients with familial Mediterranean fever.	KIR2DS3 KIR2DS4 KIR3DL2	2.07e-06	16	55	3	19309280
Pubmed	Report from the killer immunoglobulin-like receptor (KIR) anthropology component of the 15th International Histocompatibility Workshop: worldwide variation in the KIR loci and further evidence for the co-evolution of KIR and HLA.	KIR2DS3 KIR2DS4 KIR3DL2	2.07e-06	16	55	3	20331834
Pubmed	[Polymorphism of killer cell immunoglobulin-like receptors gene family in Zhejiang Han population].	KIR2DS3 KIR2DS4 KIR3DL2	2.07e-06	16	55	3	16403292
Pubmed	HLA-DQA1*0505 sharing and killer immunoglobulin-like receptors in sub fertile couples: report from the 15th International Histocompatibility Workshop.	KIR2DS3 KIR2DS4 KIR3DL2	2.07e-06	16	55	3	20210919
Pubmed	Species-specific recognition of Aspergillus fumigatus by Toll-like receptor 1 and Toll-like receptor 6.	TLR1 TLR6	2.46e-06	2	55	2	22315281
Pubmed	Functional identification of transcription control sequences of the mouse Crry gene.	CR1 CR1L	2.46e-06	2	55	2	8335915
Pubmed	Role of TLR1 and TLR6 in the host defense against disseminated candidiasis.	TLR1 TLR6	2.46e-06	2	55	2	18036178
Pubmed	Identification and characterization of D8C, a novel domain present in liver-specific LZP, uromodulin and glycoprotein 2, mutated in familial juvenile hyperuricaemic nephropathy.	OIT3 UMOD	2.46e-06	2	55	2	15589826
Pubmed	Liver-specific ZP domain-containing protein (LZP) as a new partner of Tamm-Horsfall protein harbors on renal tubules.	OIT3 UMOD	2.46e-06	2	55	2	18830570
Pubmed	Crry/p65, a membrane complement regulatory protein, has costimulatory properties on mouse T cells.	CR1 CR1L	2.46e-06	2	55	2	10779754
Pubmed	The association of genetic variants in toll-like receptor 2 subfamily with allergy and asthma after hospitalization for bronchiolitis in infancy.	TLR1 TLR6	2.46e-06	2	55	2	24445834
Pubmed	Astrocyte-specific expression of a soluble form of the murine complement control protein Crry confers demyelination protection in the cuprizone model.	CR1 CR1L	2.46e-06	2	55	2	17674370
Pubmed	Altered renal tubular expression of the complement inhibitor Crry permits complement activation after ischemia/reperfusion.	CR1 CR1L	2.46e-06	2	55	2	16444293
Pubmed	[DISTRIBUTION OF TWO-LOCUS HAPLOTYPES OF MICROBIAL COMPONENT SENSOR GENES TLR1 AND TLR6 IN MAJOR POPULATIONS OF SOUTH URALS].	TLR1 TLR6	2.46e-06	2	55	2	26470427
Pubmed	Distinct receptor and regulatory properties of recombinant mouse complement receptor 1 (CR1) and Crry, the two genetic homologues of human CR1.	CR1 CR1L	2.46e-06	2	55	2	1730912
Pubmed	Association of human TLR1 and TLR6 deficiency with altered immune responses to BCG vaccination in South African infants.	TLR1 TLR6	2.46e-06	2	55	2	21852947
Pubmed	Toll-like Receptor 1 743 A>G, 1805 T>G & Toll-like Receptor 6 745 C>T gene polymorphism and tuberculosis: a case control study of north Indian population from Agra (India).	TLR1 TLR6	2.46e-06	2	55	2	24984237
Pubmed	Mesangial cell complement receptor 1-related protein y limits complement-dependent neutrophil accumulation in immune complex glomerulonephritis.	CR1 CR1L	2.46e-06	2	55	2	19740350
Pubmed	Complement inhibitor, complement receptor 1-related gene/protein y-Ig attenuates intestinal damage after the onset of mesenteric ischemia/reperfusion injury in mice.	CR1 CR1L	2.46e-06	2	55	2	11698469
Pubmed	Expression of a Crry/p65 is reduced in acute lung injury induced by extracellular histones.	CR1 CR1L	2.46e-06	2	55	2	34709768
Pubmed	The murine complement regulator Crry: new insights into the immunobiology of complement regulation.	CR1 CR1L	2.46e-06	2	55	2	11915940
Pubmed	Mouse Crry/p65. Characterization of monoclonal antibodies and the tissue distribution of a functional homologue of human MCP and DAF.	CR1 CR1L	2.46e-06	2	55	2	7691944
Pubmed	The murine complement receptor gene family. Analysis of mCRY gene products and their homology to human CR1.	CR1 CR1L	2.46e-06	2	55	2	2911011
Pubmed	Cutting edge: functional interactions between toll-like receptor (TLR) 2 and TLR1 or TLR6 in response to phenol-soluble modulin.	TLR1 TLR6	2.46e-06	2	55	2	11123271
Pubmed	SNPs in the exons of Toll-like receptors are associated with susceptibility to type 1 diabetes in Chinese population.	TLR1 TLR6	2.46e-06	2	55	2	25261617
Pubmed	Genetic ancestry effects on the distribution of toll-like receptors (TLRs) gene polymorphisms in a population of the Atlantic Forest, São Paulo, Brazil.	TLR1 TLR6	2.46e-06	2	55	2	29175392
Pubmed	Prevention of collagen-induced arthritis in mice transgenic for the complement inhibitor complement receptor 1-related gene/protein y.	CR1 CR1L	2.46e-06	2	55	2	12902517
Pubmed	Cutting edge: treatment of complement regulatory protein deficiency by retroviral in vivo gene therapy.	CR1 CR1L	2.46e-06	2	55	2	17015675
Pubmed	Deletion of Crry, the murine ortholog of the sporadic Alzheimer's disease risk gene CR1, impacts tau phosphorylation and brain CFH.	CR1 CR1L	2.46e-06	2	55	2	23153828
Pubmed	The Roles of TLR Gene Polymorphisms in Atherosclerosis: A Systematic Review and Meta-Analysis of 35,317 Subjects.	TLR1 TLR6	2.46e-06	2	55	2	28474755
Pubmed	Expansion of the complement receptor gene family. Identification in the mouse of two new genes related to the CR1 and CR2 gene family.	CR1 CR1L	2.46e-06	2	55	2	2952719
Pubmed	Central nervous system-targeted complement inhibition mediates neuroprotection after closed head injury in transgenic mice.	CR1 CR1L	2.46e-06	2	55	2	12973023
Pubmed	Central nervous system-targeted expression of the complement inhibitor sCrry prevents experimental allergic encephalomyelitis.	CR1 CR1L	2.46e-06	2	55	2	10586048
Pubmed	In vivo correction of complement regulatory protein deficiency with an inhibitor targeting the red blood cell membrane.	CR1 CR1L	2.46e-06	2	55	2	16301687
Pubmed	Expression dynamics of Crry at the implantation sites in normal pregnancy and response against miscarriage induction.	CR1 CR1L	2.46e-06	2	55	2	36450590
Pubmed	DOCK2 is a microglial specific regulator of central nervous system innate immunity found in normal and Alzheimer's disease brain.	DOCK2 PTGER2	2.46e-06	2	55	2	19729484
Pubmed	Complement regulatory protein Crry/p65-mediated signaling in T lymphocytes: role of its cytoplasmic domain and partitioning into lipid rafts.	CR1 CR1L	2.46e-06	2	55	2	16301324
Pubmed	The extended multidomain solution structures of the complement protein Crry and its chimeric conjugate Crry-Ig by scattering, analytical ultracentrifugation and constrained modelling: implications for function and therapy.	CR1 CR1L	2.46e-06	2	55	2	12767833
Pubmed	A specific role for TLR1 in protective T(H)17 immunity during mucosal infection.	TLR1 TLR6	2.46e-06	2	55	2	22778390
Pubmed	The murine complement receptor gene family. III. The genomic and transcriptional complexity of the Crry and Crry-ps genes.	CR1 CR1L	2.46e-06	2	55	2	2307848
Pubmed	Complement regulatory protein Crry/p65 costimulation expands natural treg cells with enhanced suppressive properties in proteoglycan-induced arthritis.	CR1 CR1L	2.46e-06	2	55	2	21380996
Pubmed	Regulation of complement activity via the alternative pathway in placentas of mouse spontaneous abortions.	CR1 CR1L	2.46e-06	2	55	2	20484840
Pubmed	Natural killer cell receptor repertoire and their ligands, and the risk of CMV infection after kidney transplantation.	KIR2DS3 KIR2DS4 KIR3DL2	2.50e-06	17	55	3	19032228
Pubmed	The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.	KIR2DS3 KIR2DS4 KIR3DL2	2.50e-06	17	55	3	20173784
Pubmed	The role of killer immunoglobulin-like receptor haplotypes on the outcome of unrelated donor haematopoietic SCT for thalassaemia.	KIR2DS3 KIR2DS4 KIR3DL2	2.50e-06	17	55	3	20173792
Pubmed	Role of killer cell immunoglobulin-like receptor gene content and human leukocyte antigen-C group in susceptibility to human T-lymphotropic virus 1-associated myelopathy/tropical spastic paraparesis in Peru.	KIR2DS3 KIR2DS4 KIR3DL2	2.50e-06	17	55	3	20483367
Pubmed	[Effects of killer immunoglobulin-like receptor and human leukocyte antigen class I ligand on the prognosis of related donor hematopoietic stem cell transplantation].	KIR2DS3 KIR2DS4 KIR3DL2	2.50e-06	17	55	3	19968064
Pubmed	[Analysis of natural killer cell immunoglobulin-like receptor genes in Chinese].	KIR2DS3 KIR2DS4 KIR3DL2	2.50e-06	17	55	3	19218127
Pubmed	Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection.	KIR2DS3 KIR2DS4 KIR3DL2	2.50e-06	17	55	3	20878400
Pubmed	Killer cell immunoglobulin-like receptor gene diversity in the Tibetan ethnic minority group of China.	KIR2DS3 KIR2DS4 KIR3DL2	2.50e-06	17	55	3	20650299
Pubmed	Killer cell immunoglobulin-like receptor gene polymorphisms in patients with leukemia: possible association with susceptibility to the disease.	KIR2DS3 KIR2DS4 KIR3DL2	2.50e-06	17	55	3	19450876
Pubmed	Distribution of killer-cell immunoglobulin-like receptor genes in Eastern mainland Chinese Han and Taiwanese Han populations.	KIR2DS3 KIR2DS4 KIR3DL2	2.50e-06	17	55	3	19761533
Pubmed	Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis.	KIR2DS3 KIR2DS4 KIR3DL2	3.00e-06	18	55	3	19630074
Pubmed	Influence of HLA class I and HLA-KIR compound genotypes on HIV-2 infection and markers of disease progression in a Manjako community in West Africa.	KIR2DS3 KIR2DS4 KIR3DL2	3.00e-06	18	55	3	20519398
Pubmed	Signatures of natural selection and coevolution between killer cell immunoglobulin-like receptors (KIR) and HLA class I genes.	KIR2DS3 KIR2DS4 KIR3DL2	3.00e-06	18	55	3	20200544
Pubmed	Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.	KIR2DS3 KIR2DS4 KIR3DL2	3.00e-06	18	55	3	19046302
Pubmed	Effect of killer immunoglobulin-like receptors in the response to combined treatment in patients with chronic hepatitis C virus infection.	KIR2DS3 KIR2DS4 KIR3DL2	3.00e-06	18	55	3	19846535
Pubmed	Association of killer cell immunoglobulin-like receptors and human leukocyte antigen-C genotypes in South Brazilian with type 1 diabetes.	KIR2DS3 KIR2DS4 KIR3DL2	3.00e-06	18	55	3	20580654
Pubmed	Distribution of killer cell immunoglobulin-like receptor genes in the mestizo population from Venezuela.	KIR2DS3 KIR2DS4 KIR3DL2	3.00e-06	18	55	3	20210918
Pubmed	KIR and HLA gene combinations in Vogt-Koyanagi-Harada disease.	KIR2DS3 KIR2DS4 KIR3DL2	3.56e-06	19	55	3	18571006
Pubmed	Association between killer-cell immunoglobulin-like receptor genotypes and leprosy in Brazil.	KIR2DS3 KIR2DS4 KIR3DL2	3.56e-06	19	55	3	18778326
Pubmed	Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with solid tumors.	KIR2DS3 KIR2DS4 KIR3DL2	3.56e-06	19	55	3	20600442
Pubmed	Killer cell immunoglobulin-like receptor gene diversity in a Southern Brazilian population from the state of Paraná.	KIR2DS3 KIR2DS4 KIR3DL2	3.56e-06	19	55	3	18848853
Pubmed	Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay.	KIR2DS3 KIR2DS4 KIR3DL2	4.19e-06	20	55	3	20193031
Pubmed	HLA and KIR frequencies in Sicilian Centenarians.	KIR2DS3 KIR2DS4 KIR3DL2	4.19e-06	20	55	3	20426625
Pubmed	Activating killer cell immunoglobulin-like receptors 3DS1 and 2DS1 protect against developing the severe form of recurrent respiratory papillomatosis.	KIR2DS3 KIR2DS4 KIR3DL2	4.88e-06	21	55	3	19861144
Pubmed	Distribution of KIR genes in the population of unrelated individuals homozygous for ancestral haplotype AH8.1 (HLA-A1B8DR3).	KIR2DS3 KIR2DS4 KIR3DL2	5.64e-06	22	55	3	20492596
Pubmed	Duplication and divergence of the amino-terminal coding region of the complement receptor 1 (CR1) gene. An example of concerted (horizontal) evolution within a gene.	CR1 CR1L	7.36e-06	3	55	2	2295627
Pubmed	Heterozygous Arg753Gln polymorphism of human TLR-2 impairs immune activation by Borrelia burgdorferi and protects from late stage Lyme disease.	TLR1 TLR6	7.36e-06	3	55	2	16081826
Pubmed	Genetic variation in the toll-like receptor gene cluster (TLR10-TLR1-TLR6) and prostate cancer risk.	TLR1 TLR6	7.36e-06	3	55	2	18752252
Pubmed	Polymorphisms in TLR1, TLR6 and TLR10 genes and the risk of Graves' disease.	TLR1 TLR6	7.36e-06	3	55	2	25028161
Pubmed	Sublethal infection of C57BL/6 mice with Salmonella enterica Serovar Typhimurium leads to an increase in levels of Toll-like receptor 1 (TLR1), TLR2, and TLR9 mRNA as well as a decrease in levels of TLR6 mRNA in infected organs.	TLR1 TLR6	7.36e-06	3	55	2	15731092
Pubmed	Recognition of Coxiella burnetii by toll-like receptors and nucleotide-binding oligomerization domain-like receptors.	TLR1 TLR6	7.36e-06	3	55	2	25246533
Pubmed	The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors.	TLR1 TLR6	7.36e-06	3	55	2	11095740
Pubmed	IFNs activate toll-like receptor gene expression in viral infections.	TLR1 TLR6	7.36e-06	3	55	2	11607792
Pubmed	Common genetic variation and novel loci associated with volumetric mammographic density.	INHBB HABP2	7.36e-06	3	55	2	29665850
Pubmed	[Association of polymorphisms in toll-like receptor genes with atopic dermatitis in the Republic of Bashkortostan].	TLR1 TLR6	7.36e-06	3	55	2	25850295
Cytoband	19q13.4	A1BG KIR2DS3 KIR2DS4 KIR3DL2 LILRB1	4.31e-08	79	55	5	19q13.4
Cytoband	4p14	TLR1 TLR6	1.18e-03	42	55	2	4p14
Cytoband	Ensembl 112 genes in cytogenetic band chr4p14	TLR1 TLR6	2.96e-03	67	55	2	chr4p14
Cytoband	Ensembl 112 genes in cytogenetic band chr19q13	A1BG SIGLEC6 DYRK1B KIR2DS4 KIR3DL2 LILRB1	2.97e-03	1192	55	6	chr19q13
GeneFamily	ADAM metallopeptidase domain containing\|CD molecules	DPP4 CD3E TNFSF14 SIGLEC6 TLR1 TLR6 KIR2DS4 CR1 KIR3DL2 LILRB1	1.02e-08	394	40	10	471
GeneFamily	CD molecules\|Killer cell immunoglobulin like receptors	KIR2DS3 KIR2DS4 KIR3DL2	8.00e-06	18	40	3	620
GeneFamily	CD molecules\|Toll like receptors	TLR1 TLR6	2.12e-04	10	40	2	948
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	APOH CR1 CR1L	2.70e-04	57	40	3	1179
GeneFamily	Complement system\|Sushi domain containing	CR1 CR1L	2.87e-03	36	40	2	492
GeneFamily	Endogenous ligands	RSPO3 INHBB HEBP1	1.54e-02	237	40	3	542
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Lymphocytic\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DOCK2 CD3E TNFSF14 PTGER2 KIR3DL2	2.02e-06	174	53	5	ecee7e012ccd7876fb9df8aa939f8eb05b0c2b13
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Lymphocytic-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DOCK2 CD3E TNFSF14 PTGER2 KIR3DL2	2.02e-06	174	53	5	693fc31bed0f560644e419fa70ef09f863425416
ToppCell	RA-17._Lymphocyte\|RA / Chamber and Cluster_Paper	DOCK2 DPP4 CD3E PTGER2 KIR3DL2	2.51e-06	182	53	5	257a7847917b6ea1d60608183d90300bfd028758
ToppCell	TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-1\|TCGA-Skin / Sample_Type by Project: Shred V9	DOCK2 RSPO3 TNFSF14 PTGER2 LILRB1	2.58e-06	183	53	5	cd00e2cd901df4b3f5f7aed747cc0b47f6d3c811
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Hematopoietic-T_cells\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DOCK2 CD3E NR4A2 TLR6 APOH	2.58e-06	183	53	5	f079179f2984def91ddf0b33d7949d5ecdbd380d
ToppCell	RA-17._Lymphocyte\|World / Chamber and Cluster_Paper	DOCK2 DPP4 CD3E PTGER2 KIR3DL2	2.58e-06	183	53	5	6397f684a50346fc42cccb5afbe10350f4b2d9b0
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Hematopoietic-T_cells-ILCP\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DOCK2 CD3E NR4A2 TLR6 APOH	2.58e-06	183	53	5	49e8ee16e4f677f9f649e2a2faf1b9b16c5a27e7
ToppCell	(1)_T_CD8_gd\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	CD3E TNFSF14 NR4A2 PTGER2 KIR3DL2	3.02e-06	189	53	5	62eda4bcfd21d5025ac676d524994ede22721c1d
ToppCell	PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	DPP4 IRX5 PTPRZ1 LAMA1 ETV5	3.10e-06	190	53	5	625c08a0e5227efc46daa512fd579c3938ff76c7
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK2 TLR1 ETV5 CR1 LILRB1	3.10e-06	190	53	5	788ff9d8888d2dd25b7e1d7e0e5d57751ce86f19
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK2 TLR1 ETV5 CR1 LILRB1	3.18e-06	191	53	5	baa70781633a3fe5bf987f9d8dff3884f5167e7f
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK2 TLR1 ETV5 CR1 LILRB1	3.26e-06	192	53	5	86d792682ba51696f503c79625dd20f87bcf651f
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK2 TLR1 ETV5 CR1 LILRB1	3.26e-06	192	53	5	d0ad6a205ad50a3c523fa68676996b289eabc5de
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK2 TLR1 ETV5 CR1 LILRB1	3.35e-06	193	53	5	f597fefc54327a1ad136e2f66b6e81cc5c761eb7
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Immune\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK2 TLR1 ETV5 CR1 LILRB1	3.43e-06	194	53	5	96f16bcd393a0d3f8df479b172b5360ae5a1e663
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Immune\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK2 TLR1 ETV5 CR1 LILRB1	3.43e-06	194	53	5	0866ab6792cee274a71991d5c37a37f574ff446e
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK2 TLR1 ETV5 CR1 LILRB1	3.52e-06	195	53	5	91a3c439f10c03c5d51d904f512b6a08040edc76
ToppCell	10x5'-GI_large-bowel-Lymphocytic_T_CD4/8-lo\|GI_large-bowel / Manually curated celltypes from each tissue	CD3E TNFSF14 NR4A2 PTGER2 KIR3DL2	3.70e-06	197	53	5	2d7054234759a8dea525c26b3f7aae539ef7624c
ToppCell	10x5'-GI_large-bowel-Lymphocytic_T_CD4/8-lo-Trm_Tgd\|GI_large-bowel / Manually curated celltypes from each tissue	CD3E TNFSF14 NR4A2 PTGER2 KIR3DL2	3.70e-06	197	53	5	8546ddf096a1ca8c897b40d496bc507d79ac520e
ToppCell	MS-Multiple_Sclerosis-Lymphocyte-T/NK-MAIT\|Multiple_Sclerosis / Disease, condition lineage and cell class	DPP4 CD3E TNFSF14 NR4A2 PTGER2	3.98e-06	200	53	5	10120f474ac3de10fc8e66158969415bd3f8c1da
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Degenerative_Ascending_Thin_Limb_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	A1BG DPP4 IRX5 PTPRZ1	2.61e-05	144	53	4	163c591fedad2beb7f92531e6240e9554f90ea40
ToppCell	E18.5-samps-Mesenchymal-Pericyte-pericyte_D\|E18.5-samps / Age Group, Lineage, Cell class and subclass	RSPO3 FLNC PTPRZ1 XYLB	2.98e-05	149	53	4	dcf68eb25733b5db2893728fe4dca5c7267eb58c
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c08-GZMK-FOS_h\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	DPP4 TMPRSS15 CD3E NR4A2	3.39e-05	154	53	4	89c9c9918af32f3952790b41f1471b2c80ffce2f
ToppCell	E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Noncycling_AT2_Precursor\|E16.5-samps / Age Group, Lineage, Cell class and subclass	DPP4 IRX5 TECTB ETV5	3.48e-05	155	53	4	9cad73d0b8ead289e1073d1a2e00bbeb1228308c
ToppCell	facs-Marrow-KLS-24m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EFNA4 OIT3 MAOB GLIS2	3.66e-05	157	53	4	3c6be6995c00c4cadbd209c66bf9a87c8c238652
ToppCell	facs-Marrow-KLS-24m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EFNA4 OIT3 MAOB GLIS2	3.66e-05	157	53	4	662d5026e0e4249029fc6f3abc771d775d7bc3bb
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRZ1 LAMA1 TECTB DNAH9	3.94e-05	160	53	4	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRZ1 LAMA1 TECTB DNAH9	3.94e-05	160	53	4	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	droplet-Pancreas-Exocrine-21m-Epithelial\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	A1BG IRX5 LAMA1 APOH	4.13e-05	162	53	4	922ecea81063095b8dd9ac9f9792bf551edbb848
ToppCell	3'-Child04-06-SmallIntestine-Hematopoietic-T_cells-TRGV4_gdT\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CD3E TNFSF14 NR4A2 KIR3DL2	4.44e-05	165	53	4	9f6f3a614ac614488e9f59cf2805467ff075ccca
ToppCell	facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	A1BG TMPRSS15 APOH PTGER2	4.44e-05	165	53	4	6d315e0734079ad05336cc2c3f24d870c9105bc8
ToppCell	facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	A1BG TMPRSS15 APOH PTGER2	4.44e-05	165	53	4	84f5597b1bb75f42de9a224196bb8ac198bbe3bf
ToppCell	LPS-antiTNF-Epithelial_alveolar-Mes-like-AT2_Progenitor\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANO4 CD3E PSMA6 TBC1D12	4.76e-05	168	53	4	9e7b4b9b977e90e083f5164013e79df8bc2d492e
ToppCell	390C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)\|390C / Donor, Lineage, Cell class and subclass (all cells)	TLR1 TBC1D12 TLR6 ITGB5	4.87e-05	169	53	4	2c851b2703c7b8b656026f996f5fc027e4a79b36
ToppCell	droplet-Pancreas-Exocrine-21m-Epithelial-pancreatic_ductal_cel\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYOF IRX5 LAMA1 APOH	5.22e-05	172	53	4	c0bda7153e02bee7d0326138cc684151c404c2a1
ToppCell	390C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	TLR1 TBC1D12 TLR6 ITGB5	5.34e-05	173	53	4	1f725ff16e28636b20ef26f3fa9be8b47c89378d
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Lymphocytic-CD8-positive,_alpha-beta_T_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD3E OIT3 TNFSF14 PTGER2	5.46e-05	174	53	4	6b362b8a934a4fe6a1dd867b7c448cb3fb3ffd6a
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DPP4 MYOF MAOB NR4A2	5.46e-05	174	53	4	7d4b860e05b5931f6f9d757a68f75ff35597a47a
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Radial_glial-RGCs_early_2\|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.	ANO4 RSPO3 MYOF MORN5	5.71e-05	176	53	4	8e0ac3ad5e47614b4befabd674a40e3eaae553f3
ToppCell	LPS-antiTNF-Lymphocytic_NKT-T_cells\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK2 DPP4 CD3E NR4A2	5.71e-05	176	53	4	ea27e18407b8a13e8212830da859efeb8f158690
ToppCell	LPS-antiTNF-Lymphocytic_NKT-T_cells-T-cells\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK2 DPP4 CD3E NR4A2	5.71e-05	176	53	4	bfbab3c5b738b3b0b1540f2059d0245fbd8c0031
ToppCell	3'-GW_trimst-1-SmallIntestine-Hematopoietic-T_cells-ILC2\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CD3E TNFSF14 TLR6 PTGER2	5.83e-05	177	53	4	9828504591599619649d41a78daf7c052729c669
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_prolif-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MYOF HEBP1 ETV5 CR1L	5.96e-05	178	53	4	30d2b54462fd16222ad2e3806be6143e834b29e0
ToppCell	IIF-Lymphocyte-T_NK-gdT\|IIF / Disease, Lineage and Cell Type	CD3E TNFSF14 NR4A2 KIR3DL2	5.96e-05	178	53	4	3344d1328fd9c570c3a4b2629edec627a442d0e0
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-10\|TCGA-Colorectal / Sample_Type by Project: Shred V9	DOCK2 TLR1 TLR6 CR1	6.09e-05	179	53	4	cc079ba015326dccde955c5eafa3e4a2e40de192
ToppCell	LPS-antiTNF-Lymphocytic_NKT\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK2 DPP4 CD3E NR4A2	6.09e-05	179	53	4	ecea75c568911ff56939c9f67ab901497bd4356c
ToppCell	10x3'2.3-week_17-19-Lymphocytic_NK-T_NK\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	CD3E TNFSF14 NR4A2 KIR3DL2	6.23e-05	180	53	4	0a98d21fec67a890e75ebf0e2d23adddd77da214
ToppCell	10x3'2.3-week_17-19-Lymphocytic_NK\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	CD3E TNFSF14 NR4A2 KIR3DL2	6.23e-05	180	53	4	1c8398342d3fa4d5ca9a8a63626cc497c5291446
ToppCell	10x3'2.3-week_17-19-Lymphocytic_NK-T_NK-CD56_bright_NK\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	CD3E TNFSF14 NR4A2 KIR3DL2	6.23e-05	180	53	4	ddbab26b05f057bd78b78773381cd447bd2e2726
ToppCell	E12.5-Epithelial-epithelial_progenitor_cell-epithelial_progenitor_cell\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	DPP4 IRX5 ETV5 HABP2	6.50e-05	182	53	4	204530444e35d4977a7239ac176f477e9e5c29ab
ToppCell	367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	CD3E SLC35G2 PTGER2 LILRB1	6.64e-05	183	53	4	983ca1342ddd365e1f1df32a456394b002b10e41
ToppCell	cellseq2-Immune-Immune_Myeloid-Myeloid_Dendritic-cDC2\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DOCK2 TLR1 TLR6 LILRB1	6.64e-05	183	53	4	9840706f972387241bf1d4ba8af25efc3214a91b
ToppCell	cellseq2-Immune-Immune_Myeloid-Myeloid_Dendritic\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DOCK2 TLR1 TLR6 LILRB1	6.64e-05	183	53	4	409cb52cf4c967e52bf75a6680bcbe87f638c75d
ToppCell	Nasal_Brush-Immune-Dendritic_cells\|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X	A1BG DOCK2 DPP4 LILRB1	6.64e-05	183	53	4	b1daec831990a53e846c089cebfcf4f8440820e4
ToppCell	3'-Adult-SmallIntestine-Epithelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DPP4 TMPRSS15 MAOB HEBP1	6.78e-05	184	53	4	ed7a8e79e5723a5f5a03f542203d9e50bdef5f50
ToppCell	PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	IRX5 PTPRZ1 LAMA1 ETV5	6.78e-05	184	53	4	fa4915b0498f3069fd5ef497286445528f75187e
ToppCell	PND01-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DPP4 IRX5 MAOB ETV5	6.92e-05	185	53	4	fd51fef8c69e34c72017d8371ab0a0d7be5701f2
ToppCell	PND01-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DPP4 IRX5 MAOB ETV5	6.92e-05	185	53	4	bea26e369ae91006052b973cd89b4c49afa9e553
ToppCell	primary_auditory_cortex_(A1C)-Non-neuronal-Endothelial_Myeloid\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DOCK2 MYOF TLR1 LILRB1	7.22e-05	187	53	4	5ce7cf02990465b6f793205e4be07e8337b3570a
ToppCell	3'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DPP4 TMPRSS15 MAOB HEBP1	7.22e-05	187	53	4	9042bd0f57213a51503d9df2e4dce3209b7772d3
ToppCell	primary_auditory_cortex_(A1C)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia-Micro_L1-6_C1QC\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DOCK2 MYOF TLR1 LILRB1	7.22e-05	187	53	4	17a37fc3a1d62fef3137e5ff26a84c0b8c80e124
ToppCell	primary_auditory_cortex_(A1C)-Non-neuronal-Endothelial_Myeloid-Micro\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DOCK2 MYOF TLR1 LILRB1	7.22e-05	187	53	4	1b0eb29394040555516677b9de75c15e769c4c53
ToppCell	primary_auditory_cortex_(A1C)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DOCK2 MYOF TLR1 LILRB1	7.22e-05	187	53	4	11c773cf3dc1e725b7e4d8edd676c8a94a231d2a
ToppCell	Mid-temporal_gyrus_(MTG)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DOCK2 MYOF TLR6 LILRB1	7.37e-05	188	53	4	5df5a0890e17d19f55770525345a656253696887
ToppCell	Mid-temporal_gyrus_(MTG)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia-Micro_L1-6_C1QC\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DOCK2 MYOF TLR6 LILRB1	7.37e-05	188	53	4	9e923b0d79495ee1a3a097741a877f25d439eda3
ToppCell	LPS_only-Lymphocytic_NKT\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK2 DPP4 CD3E NR4A2	7.37e-05	188	53	4	bbe65b1c11c88ab62d8485cfc3a913ff9da89aad
ToppCell	Mid-temporal_gyrus_(MTG)-Non-neuronal-Endothelial_Myeloid-Micro\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DOCK2 MYOF TLR6 LILRB1	7.37e-05	188	53	4	14dbc985abc2012c9f53deb243d465e4175f419f
ToppCell	ILEUM-inflamed-(1)_Cytotoxic_CD8_Trm\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	DPP4 CD3E TNFSF14 NR4A2	7.37e-05	188	53	4	d26894d1066a70e4b32ae41fff1c4718f2591ba9
ToppCell	wk_15-18-Epithelial-Distal_epithelial-epi-tip_early\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	IRX5 LAMA1 ETV5 APOH	7.37e-05	188	53	4	eefd2930833d216efbd72f67541bb2d9e7d47f3b
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Monocyte-derived_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK2 TLR1 ETV5 LILRB1	7.37e-05	188	53	4	0d7296ad26e97ad91c6927a6cfe4e6e70a74c5a6
ToppCell	5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NR4A2 TLR6 CR1 LILRB1	7.37e-05	188	53	4	cb091912f9b627a78a8793a37df7f1de839f887f
ToppCell	3'-Adult-LargeIntestine-Hematopoietic-Myeloid-cDC2\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DOCK2 SIGLEC6 TLR1 LILRB1	7.52e-05	189	53	4	8419d62e6991851bdc6ad861f5c9086ff808b222
ToppCell	cellseq-Immune-Hematopoietic-Granulocytic-Neutrophil\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TNFSF14 TLR1 TLR6 CR1	7.52e-05	189	53	4	fedab592be1d6520325b8c1b659b0a4dc3f4fe4d
ToppCell	3'-Distal_airway-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RSPO3 INHBB SRM SLC35G2	7.52e-05	189	53	4	e002dbb2138a6264be23f3b8148275a0cef351ef
ToppCell	Mid-temporal_gyrus_(MTG)-Non-neuronal-Endothelial_Myeloid\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DOCK2 MYOF TLR6 LILRB1	7.52e-05	189	53	4	e9fe8d17f4b7cca9bbf3655047e27b2fec5060c1
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-MAIT\|lymph-node_spleen / Manually curated celltypes from each tissue	DPP4 CD3E TNFSF14 PTGER2	7.52e-05	189	53	4	afe3a4fe7c10eeeb7064129778d940269c9acbef
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK2 TLR1 ETV5 LILRB1	7.68e-05	190	53	4	7c402aa47f1bd7decacc366c1ed1a37e39b95c73
ToppCell	E17.5-Epithelial-epithelial_progenitor_cell-epithelial_progenitor_cell\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	DPP4 IRX5 MAOB ETV5	7.68e-05	190	53	4	8e9ba1f1af520564a1a7dfa9ef74ef5f0d0bf0d5
ToppCell	droplet-Lung-immune-endo-depleted-3m-Epithelial\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IRX5 ETV5 DNAH9 MORN5	7.68e-05	190	53	4	edc0a0eb17abbecb0f06d302be3d4f8c1dd4f333
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Radial_glial-RGCs_early_2\|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type.	RSPO3 IRX5 ITGB5 MORN5	7.83e-05	191	53	4	06107849463a1ccb78a5ccd3ae31619ef6bedda3
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM\|lymph-node_spleen / Manually curated celltypes from each tissue	CD3E NR4A2 PTGER2 KIR3DL2	7.83e-05	191	53	4	f802a4686ecf00e8302047bfe23356f24b266cf8
ToppCell	Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DOCK2 TLR1 CR1 ITGB5	7.83e-05	191	53	4	24d75b7e1d6fb9d24aa7844f584ee888a449841f
ToppCell	10x5'v1-week_14-16-Mesenchymal_fibro-stroma-endosteal_fibroblast\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	RSPO3 FLNC DNAH9 ITGB5	7.83e-05	191	53	4	44b1f62fdee03b157fe545f2ae6ff84f8929a8ac
ToppCell	mild_COVID-19-gd_T\|mild_COVID-19 / disease group, cell group and cell class (v2)	CD3E TNFSF14 NR4A2 KIR3DL2	7.83e-05	191	53	4	0e43c097b92aaa831811d60e033262999e79dcd7
ToppCell	wk_20-22-Epithelial-Distal_epithelial_progenitor\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	IRX5 PTPRZ1 LAMA1 ETV5	7.99e-05	192	53	4	fa2420d6117d4800f60ef6a24bcf8bf54593cd1f
ToppCell	wk_20-22-Epithelial-Distal_epithelial_progenitor-epi-tip_late\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	IRX5 PTPRZ1 LAMA1 ETV5	7.99e-05	192	53	4	87b60014202633a4f6d19b09a5dd9276c2edecfb
ToppCell	wk_15-18-Hematologic_Lymphocytic-T_&_ILC-ILC2\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	DPP4 CD3E TNFSF14 PTGER2	7.99e-05	192	53	4	017f613b1b9c0bd0842e5c1e71d3ac60dd89eadd
ToppCell	3'-Child04-06-SmallIntestine-Hematopoietic-T_cells-gdT\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CD3E NR4A2 PTGER2 KIR3DL2	7.99e-05	192	53	4	a0eb043d6f18f77c6135b4f313c3112529956f5b
ToppCell	PCW_07-8.5-Epithelial-Epithelial_alveolar-distal\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	IRX5 PTPRZ1 LAMA1 ETV5	7.99e-05	192	53	4	b7c01e12b3e9be960a741b08835f1dfff65d0d47
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	ANO4 ETV5 PTGER2 ITGB5	7.99e-05	192	53	4	c4efc170852abbcf0c53c2b0f8a0cc9fe7f116c8
ToppCell	NS-control-d_0-4-Lymphoid-Treg\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	A1BG DOCK2 DPP4 CD3E	7.99e-05	192	53	4	ef252dd9df161f665f53c047c0514381f80d6683
ToppCell	tumor_Lymph_Node_/_Brain-T/NK_cells-Cytotoxic_CD8+_T\|T/NK_cells / Location, Cell class and cell subclass	CD3E NR4A2 PTGER2 LILRB1	7.99e-05	192	53	4	82e6a818b6c56a1556d2a1aea2e56676369556df
ToppCell	E18.5-Epithelial\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DPP4 IRX5 MAOB ETV5	7.99e-05	192	53	4	75bc06ce38478f06ba29a2cc3d238aa26e87a951
ToppCell	11.5-Airway-Epithelial-Bud_tip_progenitor\|Airway / Age, Tissue, Lineage and Cell class	DPP4 IRX5 PTPRZ1 ETV5	8.15e-05	193	53	4	f0a07bb221a497a9f7cc706045d5205269be4515
ToppCell	wk_20-22-Hematologic_Lymphocytic-T_&_ILC-Th17\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	DPP4 CD3E TNFSF14 PTGER2	8.15e-05	193	53	4	4112eed9327e1d5a7e829fce6b2437287e14464e
ToppCell	PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_CTGF^high_distal_(3)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	IRX5 PTPRZ1 LAMA1 APOH	8.15e-05	193	53	4	ab78fb1603ea6f720ba2d30148fe65dccf271fe1
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK2 TLR1 ETV5 CR1	8.15e-05	193	53	4	bd08555f02db8bc903caacae57e80bb91e2556ce
ToppCell	E16.5-samps-Epithelial-Alveolar_epithelial_precursor\|E16.5-samps / Age Group, Lineage, Cell class and subclass	DPP4 IRX5 MAOB ETV5	8.15e-05	193	53	4	c1817ad675b9f9d2d3436c8b9646edf89f0d4c82
ToppCell	E16.5-samps-Epithelial\|E16.5-samps / Age Group, Lineage, Cell class and subclass	DPP4 IRX5 MAOB ETV5	8.15e-05	193	53	4	1cb5a1cffa2b4a3bfecca16b791c1992edeb237d
ToppCell	10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like-G\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MAOB PTPRZ1 DNAH9 MORN5	8.15e-05	193	53	4	c3522693439c23830d8a3f20854539ccb7a666e0
Computational	Genes in the cancer module 27.	TMPRSS15 EFNA4 TLR1 NR4A2 APOH CR1 PTGER2 ITGB5	1.12e-05	355	34	8	MODULE_27
Computational	Genes in the cancer module 46.	DPP4 TNFSF14 TLR1 NR4A2 UMOD CR1 LILRB1	1.92e-04	394	34	7	MODULE_46
Computational	Immune response.	DPP4 TNFSF14 TLR1 NR4A2 UMOD CR1 LILRB1	2.05e-04	398	34	7	MODULE_75
Computational	Neighborhood of IL2RB	KIR2DS4 PTGER2 KIR3DL2	4.00e-04	46	34	3	GNF2_IL2RB
Computational	Genes in the cancer module 557.	TMPRSS15 MAOB	5.25e-04	11	34	2	MODULE_557
Computational	Membranal receptors.	CD3E EFNA4 TNFSF14 TLR1 NR4A2 APOH ITGB5	9.90e-04	517	34	7	MODULE_64
Computational	Genes in the cancer module 424.	TLR1 APOH	1.44e-03	18	34	2	MODULE_424
Drug	Benoxinate hydrochloride [5987-82-6]; Up 200; 11.6uM; PC3; HT_HG-U133A	DPP4 IRX5 SIGLEC6 DYRK1B NR4A2 LILRB1	6.90e-06	196	54	6	3996_UP
Drug	p-nitrophenyl-alpha-D-glucopyranoside	DPP4 TNFSF14 TNS2 APOH KIR3DL2	8.16e-06	116	54	5	CID000065115
Disease	blood sedimentation	CR1 CR1L	6.86e-05	7	54	2	EFO_0004304
Disease	smoking status measurement, high density lipoprotein cholesterol measurement	PTPRZ1 ETV5	6.86e-05	7	54	2	EFO_0004612, EFO_0006527
Disease	aspergillosis (is_implicated_in)	TLR1 TLR6	9.14e-05	8	54	2	DOID:13564 (is_implicated_in)
Disease	killer cell immunoglobulin-like receptor 2DL4 measurement	KIR2DS4 KIR3DL2	2.14e-04	12	54	2	EFO_0008197
Disease	Myopia	IRX5 GJD2	3.40e-04	15	54	2	C0027092
Disease	perinatal necrotizing enterocolitis (biomarker_via_orthology)	TLR1 TLR6	4.39e-04	17	54	2	DOID:8677 (biomarker_via_orthology)
Disease	response to paliperidone, schizophrenia symptom severity measurement	ANO4 CR1 CR1L PLPPR2	6.63e-04	216	54	4	EFO_0007925, EFO_0007927
Disease	Schizophrenia	A1BG MAOB PTPRZ1 LAMA1 NR4A2 APOH LILRB1	1.09e-03	883	54	7	C0036341
Disease	tuberculosis (is_implicated_in)	TLR1 TLR6	1.21e-03	28	54	2	DOID:399 (is_implicated_in)
Disease	cholesteryl ester measurement	RSPO3 TECTB SLC35G2 APOH	1.26e-03	257	54	4	EFO_0010351
Disease	corneal resistance factor	RSPO3 MYOF GLIS2 HABP2 XYLB	1.39e-03	451	54	5	EFO_0010067
Disease	hyperuricemia	ETV5 UMOD	1.67e-03	33	54	2	EFO_0009104

Protein segments in the cluster

Peptide	Gene	Start	Entry
GAYTCYRPDVGYVQG	TBC1D12	576	O60347
KYIGGCQVGSYVHYP	ALG11	186	Q2TAA5
YEPGEEITYSCKPGY	APOH	41	P02749
YGFSVPGLYECNRYP	GJD2	221	Q9UKL4
IPRLVYAYKYGPCAG	ANO4	796	Q32M45
RTYRYSNRYCGGPGP	DYRK1B	481	Q9Y463
LGSYPYGDPAYRKNA	IRX5	106	P78411
GTYRCYGSVPHSPYQ	KIR3DL2	191	P43630
NYSCVYVDLKPPFGG	A1BG	371	P04217
GCYTTYFPPGILTQY	MAOB	396	P27338
TFQLPYCGPNKVGYY	OR10D4P	161	Q8NGN7
YCGPNKVGYYFCDIP	OR10D4P	166	Q8NGN7
GTYRCYGSVPHSPYQ	KIR2DS4	96	P43632
IIAPTGYYGNYCEGS	INHBB	321	P09529
LPQVYYFGPCGKYNA	CSNK1G1	101	Q9HCP0
FGYKCALPNRPGVYA	TMPRSS15	991	P98073
GVPQVYYFGPCGKYN	CSNK1G2	101	P78368
GGYYVYRLTKPSVCF	OIT3	126	Q8WWZ8
PLLDYGQYVQYCPGT	PTGER2	171	P43116
PGYESCQAEGPRAYK	EFNA4	81	P52798
GVFECEYYPVVPGKY	FLNC	531	Q14315
GTYRCYGSVPHSPYQ	KIR2DS3	96	Q14952
KYYQLRCSGPGLPLY	DPP4	466	P27487
CLYNYCAYDRKPPSG	ETV5	116	P41161
KPYVCPYEGCNKRYS	GLIS2	261	Q9BZE0
DKYYIYNGSLTSPPC	PTPRZ1	226	P23471
SYTAPRYQTNPCIGY	ITGB5	191	P18084
YYKGYAAGAQPRPSA	RBBP6	841	Q7Z6E9
CYDSTYAKPYPGPEA	PLPPR2	51	Q96GM1
GPLTCEKDGTYYVYG	HABP2	511	Q14520
LRPKPDYFAVGYYGQ	DOCK2	1336	Q92608
GTYLNYECRPGYSGR	CR1	66	P17927
GTSLKYECRPEYYGR	CR1	516	P17927
GTSLKYECRPEYYGR	CR1	966	P17927
PIGTYLNYECRPGYS	CR1L	56	Q2VPA4
EQSGYYVCYPRGSKP	CD3E	91	P07766
YSCPVYKTSQRGPTY	DNAH9	4446	Q9NYC9
NYSTGYDVKPPCLYQ	NR4A2	66	P43354
PVSRSYGGQYRCYGA	LILRB1	286	Q8NHL6
VCYYQEAPFGPSGYR	SLC35G2	151	Q8TBE7
PGGTSYERYDCYKVP	NDUFB9	86	Q9Y6M9
CIDGYYRPHKVSPYE	LAMA1	376	P25391
CRLPTTLPASYYGYG	SIGLEC6	51	O43699
KSYCGTQSEYKPPIY	TECTB	81	Q96PL2
PDSYKCDYPESYRGT	TLR1	551	Q15399
EQGPQVYKCDPAGYY	PSMA6	146	P60900
ACAGGYYVYNLTAPP	UMOD	266	P07911
YYIYSKVQLGGVGCP	TNFSF14	141	O43557
PYPCSYCGRSFRYKQ	ZNF398	566	Q8TD17
YYVQRYGFPPGCKVV	XYLB	261	O75191
KARGCAYPAPYLDEY	UBR1	1681	Q8IWV7
PSGYYGTRYPDINKC	RSPO3	81	Q9BXY4
VAYAYCTIPTYPSGQ	SRM	231	P19623
PDSYKCDYPESYRGS	TLR6	556	Q9Y2C9
LVTYSYGGAVPSYCP	TNS2	786	Q63HR2
YGGAVPSYCPAYGRV	TNS2	791	Q63HR2
YFCTGYDPPMKPYGR	HEBP1	166	Q9NRV9
IPKGYYDCGDGFYNP	MORN5	116	Q5VZ52
PCYLNLYGSPREYTG	MYOF	501	Q9NZM1